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Objective: Stentless valves convey important hemodynamic benefits but are 
used selectively depending on aortic root structure. The Freestyle valve 
(Medtronic, Inc, Minneapolis, Minn) is a versatile device that can be 
implanted by different methods depending on operating conditions. We 
aimed to demonstrate that a stentless valve could be used in every patient 
without increased r isk of morbidity or mortality. We documented the effects 
of this valve on clinical outcome and left ventricular mechanics. Methods: 
The Freestyle valve was implanted by the modified subcoronary method 
into 200 consecutive unselected patients who received a tissue valve in the 
aortic position and by root replacement in 2. Forty-three percent were older 
than 75 years. Forty percent underwent coronary bypass. Detailed clinical 
and echocardiographic follow-up (Food and Drug Administration protocol) 
was used out to 3 years. Results: Mean ischemic time was 43 - 6 minutes for 
isolated aortic valve replacement and 63 - 14 minutes with concomitant 
procedures. Thirty-day mortality was 6%, none of the deaths being valve 
related. Hemodynamic function improved progressively with falling valve 
gradients and increased effective orifice areas. Left ventricular mass fell within 
normal limits over 2 years, but at 3 years there was a non-valve-related 
upswing. No instances of valve thrombosis, hemolysis, or paravalvular leak 
were noted. Less than 5% had mild to moderate aortic regurgitation. Conclu- 
sions: The Freestyle valve can be used in virtually every patient with aortic valve 
disease and provides superlative hemodynamic outcome. Hospital mortality 
and morbidity are similar to those reported for stented valves in an elderly 
population. (J Thorac Cardiovasc Surg 1998;116:477-84) 
A ortic valve disease in elderly patients is domi- nated by calcific aortic stenosis. For worthwhile 
event-free survival at great age it is important o 
achieve rapid improvement in ventricular mechan- 
ics, functional class, and quality of life without 
surgical or valve-related morbidity. 1'2 The type of 
prosthesis has an important bearing on postopera- 
tive left ventricular function, particularly in smaller 
sizes)' 4 Stentless aortic bioprostheses convey im- 
portant hemodynamic benefits, in contrast o the 
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nonphysiologic flow profile and residual pressure 
gradients across mechanical valves or stented bio- 
prostheses. 5' ~ Just as homograft or pulmonary au- 
tograft aortic valve replacement results in rapid 
resolution of left ventricular hypertrophy in the 
young, similar benefts are achieved for the elderly 
with stentless xenografts. J'6 Nevertheless, their 
widespread use has been restricted by perceived 
difficulties of implantation with prolonged myocar- 
dial ischemic and cardiopulmonal3~ bypass times° 
Consequently, we sought to address the criticism 
that stentless valves are suitable only for selected 
patients without aortic root calcification or discrep- 
ancy between the diameters of the anulus and 
sinotubular junction. This article describes our ex- 
perience, including the learning curve, in 202 con- 
secutive unselected patients, operated on by 1 sur- 
geon (S.W.), who received a bioprosthesis in the 
aortic position. During this series no patient older 
than 70 years received a mechanical valve, and no 
patient received a stented bioprosthesis. 
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Fig. 1. Technical aspects of Freestyle valve implantation. A, Transverse aortotomy with stay sutures in 
place and the first valve sutures at the base of the inner lcaflet riangle. Valve size is chosen to fit the anulus 
and fill the aortic root. B, Simple interrupted valve sutures in the anulus and valve inflow. The porcine 
coronaries are closer together than in the human coronary ostia. C, The porcine aortic sinuses (left and 
right) are removed after the valve inflow sutures are tied. This ensures accurate apposition without 
commissural distortion. D, The outflow suture line joins the crest of the trimmed Freestyle valve to the 
transverse aortotomy. In the event of an occluded right coronary ostium and coronary bypass, the right 
coronary sinus need not be excised. Closure of the aortotomy effectively "suspends" the valve within the 
aortic root and prevents cusp prolapse. 
Patients and methods 
The series comprised 115 male (57%) and 87 fcmale 
(43%) patients aged 30 to 86 years. Mean age at implan- 
tation was 73 years. Only 18 patients (9%) were younger 
than 65 years. These were patients who declined a me- 
chanical valve or would not accept anticoagulation with 
warfarin. Eighty-seven patients (43%) were older than 75 
years of age. One hundred forty-two (70%) were in New 
York Heart Association (NYHA) class III or IV. One 
hundred sixty-one patients (80%) werc in sinus rhythm 
and 2 had a pre-existing pacemaker for heart block. The 
remainder had atrial fibrillation or flutter. One hundred 
ten patients (55%) had coronary artery disease and 81 
(40%) underwent concomitant coronary artery surgery. 
One hundred eighty-four patients (91%) had critical 
aortic stcnosis, of whom 47 (23%) had an element of 
aortic regurgitation. The remainder were operated on for 
severe aortic regurgitation. Two patients had active native 
valve endocarditis and 1 had an acute type A dissection. 7 
Eleven patients underwent reoperation for a failed bio- 
prosthesis (n = 9), mechanical valve (n = 1), or homograft 
(n = 1). With informed consent and ethical committee 
approval, all patients were prospectively entered into a 
clinical trial approved by the US Food and Drug Admin- 
istration (FDA) with detailed serial echocardiographic 
follow-up. 
Surgical methods. In 200 patients the porcine aortic 
cylinder (Freestyle valve, Medtronic, Inc, Minneapolis, 
Minn) was implanted by the modified subcoronary tech- 
nique described by the author 8 (Fig. 1, A to D). This 
method was used irrespective of the degree and extent of 
calcification or discrepancy between annular size and 
sinotubutar junction for these patients. Two patients 
underwent aortic root replacement for "porcelain" aorta, 
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Table I. Mortality and valve-related morbidity after 
Freestyle valve replacement 
Early Late Freedom from 
events* eventsj" event (1 YO¢ 
Standard 
Items" n % n % % error 
All deaths 12 6.0 16 6.1 88.2 2.5 
Cardiac deaths 3 3.0 3 1.1 95.2 1.7 
Permanent eurologic 5 2.5 0 0 97.2 1.2 
event 
Transient neurologic 1 0.5 1 0.4 99.4 0.6 
event 
Valve thrombosis 0 0 0 0 100 0 
Hemolysis 0 0 0 0 100 0 
Paravalvular leak 0 0 0 0 100 0 
Endocarditis 0 0 1 0.4§ 99.3 0.7 
Anticoagulation-related 2 1.0 2 0.8 97.5 1.2 
bleeding 
Reoperation 0 0 2 0.3§ 98.8 0.9 
*Within 30 days of operation, percent of202 patients. 
tEvents after 30 days, rate calculated aspercent per patient-year (linear- 
ized rate over 266 cumulated patient-years excluding the first 30 days of 
implant). 
:}:Freedom from the first event was calculated using the life table method 
with intervals of1 month and one-quarter y ar. n, number ofpatients. 
§One reoperation was for endocarditis, in the same patient. 
which followed dense mediastinal irradiation for breast 
cancer. 
Both surgical techniques have been described in detail, 8
but with increasing experience some key points are worth 
reiterating. For the modified subcoronary method the 
valve size is chosen to provide a snug fit within the human 
aortic root. In some patients it may be difficult to accom- 
modate the height of the inflow Dacron cloth beneath the 
porcine right coronary artery under the human right 
coronary artery. Distortion through bending of the Free- 
style inflow may cause obstruction, prosthetic regurgita- 
tion, or contact of the xenograft cusp with the Dacron 
fabric (Fig. 2). Avoidance of this problem is part of the 
surgical learning curve. In 12 patients (6%) we rotated the 
valve so that the elevated part of the Dacron cloth was 
positioned in the human noncoronary sinus. When the 
right coronary ostium was completely occluded (n = 9; 
4.5%), the porcine right coronal?/sinus was left intact and 
a bypass graft constructed to the distal right coronary 
artery. 
Valve sizing relied entirely on the native valve anulus 
size after valve excision and decalcification. The diameter 
of the sinotubular junction was irrelevant because this 
part of the human aorta was tailored to fit the outflow of 
the Freestyle valve. The porcine noncoronary sinus was 
left intact o ensure accurate alignment of the 2 attached 
commissures, which simplifies alignment of the third. The 
mean valve size implanted was 23.4 _+ 1.9 ram. Only 3 
patients (1.5%) received a size 19 valve and 23 (11.5%) a 
27-mm valve. For the patient with acute type A dissection, 
the modified subcoronary method was used to exclude the 
dissected tissues, and then the ascending aorta was re- 
LCA @ LCA 
RCA 
Fig. 2. Potential for a technical error, which produces an 
elevated transvalvular g adient after Freestyle valve im- 
plantation, if the distance between the valve anulus and 
right coronary ostium is less than the height of the inflow 
cloth beneath the porcine right coronary, the cloth may be 
buckled. This can be avoided by rotating the porcine right 
coronary sinus to the human noncoronary sinus. RC~I, 
Right coronary artery; LCA, left coronary artery. 
placed with a 26-mm Dacron graft (Hemashield, Meadox 
Medicals, Inc, Oakland, NJ). 7 
We initially elected to prescribe warfarin for all patients 
for 3 months, aiming for an international normalized ratio 
(INR) of 2.0 to 2.5 for paticnts in sinus rhythm. Those in 
atrial fibrillation were administered anticoagulants contin-. 
uously to maintain an INR of 2.5 to 3.5 unless atrial 
fibrillation reverted to sinus rhythm. However, when 2 
patients older than 80 years had anticoagulant-related 
cerebral hemorrhage (Table I), we reverted to a policy of 
using only aspirin, 75 mg daily, for patients in sinus 
rhythm. In total, 84 patients (42%) received warfarin and 
29 (15%) received neither warfarin nor aspirin. 
Follow-up studies. All patients were subject o detailed 
clinical and echocardiographic follow-up at intervals of 6 
and then 12 months according to FDA guidelines for valve 
studies. 
Echocardiography. Transthoracic echocardiography was 
performed at the time of discharge from the hospital and 
then at 6 months, 12 months, and annually. Echocardio- 
grams were recorded with the Toshiba 380A echocardio- 
graphic system, with a 2.5-MHZ phased-array transducer 
(Toshiba Corp, Tokyo, Japan). The protocols were de- 
scribed previously in detail. "~ Standard left ventricular 
M-mode echocardiograms were recorded and stored on 
videotape at a speed of 50 ram/s, with simultaneous 
electrocardiogram nd phonocardiogram. From an apical 
5-chamber view, flow velocities in the outflow tract (2.5 
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Table II. Changes in left ventricular hemodynamics, tentless valve performance, and ventricular mass index 
during follow-up (mean +_ SD) 
Time after AVR (too) One-way ANOVA 
Variables Discharge (n = 146) 6 (n = 108) 12 (n = 109) 24 (n = 84) 36-48 (n = 50) P value 
Hear t  rate (beats/min) 82 _+ 17 74 + 13" 73 _+_ 13" 69 ÷ 11" 68 ± t3" < .001 
Systolic BP (ram Hg) 138 -+ 22 136 + 19 139 ± 21 148 + 22* 146 ± 26* .001 
LV SVI (ml/m 2) 35 _+_ 12.9 35 + 12.6 38 _+ 11.8 43 + 14.7" 43 _+ 11.9" < .001 
LVOT area (cm 2) 3.4 ± 1.0 3.3 + 0.7 3.3 _+ 0.8 3.4 + 0.8 3.3 ± 0.9 - .644 
LVOT TVI  (cm) 19 .+ 5.7 20 + 5.9 21 _+ 5.6* 24 _+ 6.9* 24 ± 5.7* < .001 
AV peak velocity (cm/s) 220 .+ 52 195 + 45* 193 _+ 50* 199 -- 53* 199 ± 50* < .001 
AV TVI  (cm) 35 _+ 9.2 36 + 10.7 36 _+ 11.0 37.8 + 11.9 37.7 ± 1:l.1 - .308 
AV EOA (cm 2) 1.9 _+ 0.83 1.9 + 0.62 2.0 _+ 0.70 2.2 ÷ 0.77* 2.2 _+ 0.73* = .002 
Mean AV PG (mm Hg) 7.5 .+ 4.7 5.4 + 3.1" 5.2 _+ 3.5* 5.3 - 3.8* 5.2 _+ 3.9* < .001 
EOA/LVOT area (%) 56 _+ 15.9 56 + 11.9 60 ,+ 13.7" 64 + 12.8" 67 _+ 12.2" < .001 
T/R ratio 0.59 .+ 0.20 0.50 + 0.18" 0.45 ,+ 0.11" 0.45 + 0.14" 0.52 ± 0.13" < .001 
LV MI (g/m 2) 146 .+ 55 125 + 41" 109 _+ 38* 109 _+ 39* 128 _+ 51" < .001 
LV SWI (mJ/m 2) 475 -+ 179 471 + 174 510 _+ 167 592 _+ 234* 555 +_ 194" < .001 
Myocardial  SW (mJ/cm 3) 3.6 .+ 1.68 4.1 + 1.90 5.2 ± 2.38* 5.8 -+ 2.42* 4.8 ,+ 1.92" < .001 
AVR, Freestyle aortic valve replacement; ANOVA, one-way analysis of variance with respect o time; n, number of echo study at each time point; LV,, left 
ventricle; SVI, stroke volunm index; LVOT, left ventricular outflow tract; TV/, time integral of flow velocity; EOA, effective orifice area; T/R, wall thickness 
to cavity radius; MI, mass index; SWI, stroke work index. 
*Significantly different from 0.5 month by 95% confidence interval. 
MHZ pulsed Doppler ultrasonography) and the maxi- 
mum velocity across the stentless valve (2.5 MHZ contin- 
uous wave Doppler ultrasonography) were recorded at a 
speed of 100 mm/s for off-line analysis. 1°'11 Systemic 
blood pressure was also recorded noninvasively by the 
Hewlett-Packard 66s hemodynamic monitoring system 
(Hewlett-Packard Company, Andover, Mass). 
Mean values for each measurement were derived from 
3 heartbeats in patients in sinus rhythm and from 5 beats 
in those with atrial fibrillation or a VVI pacemaker. 
End-diastolic dimension, septum thickness, posterior wall 
thickness, and end-systolic dimension were measured 
from M-mode echocardiograms. Dimensional shortening 
fraction, ejection fraction, and the ratio of the wall 
thickness to cavity radius at end-diastole were determined 
according to the criteria of the American Society of 
Echocardiography. 12 Left ventricular muscle mass was 
calculated12, 13 and indexed to the body surface area. 
Mean flow velocities and the time integral of systolic flow 
velocities in the left ventricular outflow tract and those of 
the aortic valve were derived from the Doppler record- 
ings.re', 1,, 4 Left ventricular stroke volume was calculated 
as the product of the cross-sectional area and flow-velocity 
time-integral in the outflow tract. The effective orifice 
area of the aortic valve was calculated by the continuity 
equation it and indexed to the cross-sectional area of the 
outflow tract. Mean pressure drop across the aortic valve 
was calculated from the simplified Bernoulli equation by 
taking the subvalvular (V1) and valvular (V2) mean veloc- 
ities (mean pressure drop = 4 (V22 VlS), in millimeters 
of mercury. L~ Left ventricular stroke volume index and 
cardiac index were calculated from stroke volume 
(LVSV), heart rate, and body surface area. Left ventric- 
ular stroke work, measured in millijoules, was determined 
by LVSV × (mean arterial pressure + mean net aortic 
valve pressure drop) × 0.0136 × 9.8 and indexed to body 
surface area (millijoules per square meter). ') Myocardial 
stroke work was defined as global stroke work divided by 
muscle mass volume (millijoules per cubic millimeter). 15 
Statistical analysis. Echocardiographic and hemody- 
namic data are presented as mean _+ 1 standard eviation. 
Data were analyzed by means of MINITAB statistical 
software (Release 11 for Windows, 1996; Minitab Inc, 
State College, Pa). *~' One-way analysis of variance was 
performed to test the significance of changes in each 
measurement over the follow-up time. When this was 
significant, a further comparison of 95% confidence inter- 
vals with respect to the discharge chocardiographic study 
was carried out by means of Dunnett's method, with an 
overall error rate of 0.05 and an individual error rate of 
0.02. The changes in valve performance, left ventricular 
mass index, and ejection fraction over follow-up time and 
across different valve sizes were examined by 2-way anal- 
ysis of variance. 
Results 
For  the 113 patients undergoing isolated aort ic 
valve replacement,  the mean crossclamp time was 43 
+ 6.0 minutes (range, 34-60 minutes). In 85 pat ients 
undergoing concomitant procedures the crossclamp 
time was 63 + 14 minutes (range, 34-123 minutes).  
in no pat ient  was an implant abandoned or the valve 
size changed. 
Cl inical  outcomes, Twelve deaths occurred (6% 
hospital  mortal i ty) within 30 days of the operat ion 
(Table I). Three per ioperat ive deaths occurred as a 
result of acute myocardial  infarction in elderly pa- 
tients (>75 years) with aort ic stenosis, left ventric- 
ular hypertrophy, and severe diffuse coronary artery 
disease. Two patients died on the second postoper-  
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Table III. Changes in mean valvular pressure gradient and effective orifice area during follow-up time 
(mean + SD) 
Time after AVR Two-way ANOVA 
Variable~valve size Discharge 3-6 mo 12 mo 24 mo 36-48 mo Versus time Versus size 
Mean pressure gradient (mm Hg) 
21 mm (n - 122) 11.9 + 0.6 8.0 _+ 0.6 8.2 _+ 0.6 8.4 ± 0.7 8.2 +_ 0.9 
23 mm (n = 164) 7.7 + 0.5 5.4 ± 0.6 5.0 ± 0.6 4.5 ± 0.6 4.7 ± 0.7 
25 mm (n 153) 5.6 + 0.5 4.0 ± 0.5 4.0 ± 0.5 3.4 ± 0.7 3.7 ± 1.0 
27 mm (n 58) 4.5 + 0.8 3.7 _+ 0.9 2.7 ± 0.9 4.1 ± 1.0 2.8 ± 1.3 
Effective orifice area (cm 2) 
21 mm (n 122) 1.37 -~ 0.11 1.39 _+ 0.12 1.42 ~+ 0.12 1.63 ± 0.12 1.71 ± 0.17 
23 mm (n - 164) 1.72 + 0.10 1.78 ± 0.10 1.93 _+ 0.11 2.09 ± 0.12 2.04 ± 0.14 
25 mm (n 153) 2.28 + 0.10 2.12 ± 0.10 2.29 _+ 0.10 2.60 _+ 0.13 2.66 _+ 0.19 
27 mm (n 58) 2.65 + 0.19 2.25 ± 0.15 2.85 ± 0.18 3.02 ± 0.19 3.17 ± 0.25 
P < .001 P < .001 
P<.001 P<.001 
A VR, Freestyle aortic valve replacement; ANOVA, analysis of variance; n, number of echo studies of each valve size. 
Table IV. Changes in left ventricular mass index and election fraction during follow-up time (mean + SD) 
Time after A VR Two-way ANOVA 
Variable~valve size Discharge 6 months 12 months 24 months 36-48 months Versus time Versus size 
AVR, Freestyle 
106 + 11.7 
129 + 13.2 
167 + 17.9 
P < .001 P < .001 LV mass index (g/m 2) 
21 mm (n 122) 127 + 8.1 116 ± 8.5 105 ± 8.4 95 +_ 8.8 
23 mm (n = 164) 144 + 6.0 124 ± 7.9 104 ± 7.6 109 + 8.4 128 ± 10.1 
25 mm (n - 153) 150 + 6.5 124 ~ 7.3 106 ± 7.2 112 _+ 9.3 
27 mm (n - 58) 1181 + 11.1 153 + 12.3 142 ± 12.7 134 _+ 13.2 
LV ejection fraction (%) 
21 mm (n 122) 64.8 + 2.6 65.0 ± 2.7 66.6 ± 2,7 67.0 ± 2.8 65.8 + 3.7 
23 mm (n = 164) 56.5 ± 1.9 62.3 + 2.5 63.1 ± 2.4 64.4 _+ 2.7 61.9 ± 3.2 
25 mm (n = 153) 53.1 + 2.1 56.4 -'- 2.3 57.5 + 2.3 57.8 _+ 3.0 62.3 ± 4.2 
27 mm (n - 58) 51.5 + 3.4 51.3 + 3.9 58.1 ± 4.0 54.9 _+ 4.2 46.2 + 5.7 
aortic valve replacement; ANOVA, analysis of variance; n, number of echo studies of each valve size. 
P .103 P<.001 
ative day, 1 of an extensive perioperative cerebro- 
vascular accident (CVA) and the second of left 
ventricular failure; the second death occurred in a 
moribund octogenarian (NYHA class IV) with aor- 
tic regurgitation and a "bovine" heart. The remain- 
ing patients died of stroke, mesenteric ischemia, or 
acute myocardial infarction between 8 and 21 days 
after the operation. A further 3 patients (all preop- 
eratively in NYHA class IV or V) required intra- 
aortic balloon pump support for between 2 and 7 
days after the operation for impaired left ventricular 
function without perioperative myocardial infarc- 
tion. These patients utMved with fully competent 
aortic valves. 
There were 16 (8%) late deaths, 4 of which were 
cardiac in origin. Two occurred as a result of 
myocardial infarction 2 and 8 months after the 
operation, 1 was caused by acute type A dissection 
30 months after valve replacement, and the last was 
caused by a stroke 4 months after the operation. 
Because this last patient, 77 years old, did not have 
an autopsy, the death was considered to be related 
to the study valve. Other deaths occurred as a result 
of malignant disease (n = 4), primary respiratory 
problems (n = 3), ruptured abdominal aortic aneu- 
rysm (n = 1), or were unexplained sudden deaths, 
presumed arrhythmia in patients all of whom under- 
went autopsy to rule out other valve-related disease. 
Of the 194 hospital survivors, 143 (74%) remained 
in sinus rhythm. There were 39 patients (20%) in 
atrial fibrillation, and 10 new patients required a 
pacemaker (5%). Of 111 patients assessed at 1 year, 
81% were in NYHA class I and 19% were in NYHA 
class lI. Valve-related morbidity is summarized in 
Table I. All neurologic events and anticoagulant- 
related hemorrhage are included in this table. 
Hemodynamic performance of the Freestyle 
valve. From the 194 patients discharged from the 
hospital, 497 echocardiograms were obtained with 
adequate image quality for comprehensive h mody- 
namic analysis. This included 146 echoes at dis- 
charge, 108 at 6 months, and 109, 84, and 50 echoes 
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Fig 3. Freestyle valve 2 years after implantation (photo- 
graphed uring an operation for acute type A dissection. 
The valve was conserved). 
at 1, 2, and 3 to 4 years, respectively, after implan- 
tation. These figures corresponded to 77%, 81%, 
94%, 98%, and 90% of scheduled echocardio- 
graphic follow-up, respectively. The overall changes 
in left ventricular hemodynamics and Freestyle aor- 
tic valve performance are summarized in Table II. A 
significant fall in heart rate 6 months after aortic 
valve replacement was accompanied by a reciprocal 
increase in global stroke volume index. By 24 
months systemic blood pressure had increased sig- 
nificantly. An increase in the flow velocity time 
integral in the left ventricular outflow tract was 
noted at 12 months, but the cross-sectional rea of 
the outflow tract remained unchanged. In contrast, 
the peak flow velocity across the stentless valve fell 
significantly at 6 months after implantation though 
its velocity time integral was unchanged. Thus the 
effective valve orifice area progressively increased 
from 1.9 to 2.2 cm a. This represented 56% of 
outflow tract area at hospital discharge, rising to 
67% by 3 years. This corresponded with a fall in 
calculated transvalvular mean pressure gradient 
from 7.5 to 5.2 mm Hg (Table II). Less than 5% of 
patients had more than trivial aortic regurgitation, 
and in no patient was aortic regurgitation progres- 
sive. 
By 2 years left ventricular muscle mass index had 
fallen by 25% with a corresponding decrease in 
relative wall thickness (T/R ratio). Meanwhile, myo- 
cardial stroke work increased by 60% in 2 years. 
However, at 36 to 48 months' follow-up, there was 
an upswing in LV mass index, T/R ratio, and systolic 
blood pressure (Table lI), despite the fact that 
neither the valve gradient nor the effective orifice 
area changed uring this period (Tables III and IV). 
Discussion 
It is now evident that the nonphysiologic flow 
profile and residual pressure gradients across me- 
chanical valves and stented bioprostheses are major 
determinants of late outcome. 2-4 During normal 
activity (let alone physical exercise), Doppler-mea- 
sured mean and peak pressure gradients increase 
from about 25 and 45 mm Hg at rest to 40 and 70 
mm Hg, respectively (symptom-limited Master's 
2-step test)) '17 Prosthesis-related left ventricular 
pressure increase is now emerging as the principal 
cause of incomplete regression of myocyte and left 
ventricular hypertrophy, as well as the progression 
of interstitial fibrosis. Residual gradients after valve 
replacement also result in impaired left ventricular 
diastolic function irrespective of ejection fraction. 18 
This has an important effect on late events including 
the onset of fatal congestive heart failure. Subopti- 
mal left ventricular function impairs quality of life 
and increases mortality if aortic reoperation is re- 
quired. 2
The new stentless aortic bioprostheses provide 
improved hemodynamics, rapid resolution of left 
ventricular hypertrophy, and the promise of im- 
proved durability with mitigation from early cal- 
cification through biochemical treatments. 19~21 
Superlative valve function and avoidance of anti- 
coagulation with warfarin are compelling argu- 
ments for the use of stentless bioprostheses in 
elderly patients with aortic stenosis. 22 The structure 
of the valve and aortic root is highly variable in this 
group of patients. Many have poststenotic dilatation 
with a discrepancy between anulus and sinotubular 
junction dimensions. Others have widespread calci- 
fication in the aortic sinuses, often in circumferen- 
tial distribution around the coronary ostia. There is 
wide variation in the angle (90 to 180 degrees) 
between the coronary ostia, and in bicuspid valves 
the coronary arteries may be diametrically opposite 
in the aortic root. Despite this, all patients accrue 
significant benefit from valve replacement with a 
stentless prosthesis, and we have shown in a consec- 
utive series that the Freestyle porcine aortic root can 
be used by one technique or another in virtually 
every patient. The implantation method we describe 
is reproducible, safe, and effective by accommodat- 
ing variability in the aortic root. In some patients the 
ascending aorta must be tailored to the size of the 
Freestyle outflow, and in the event of very severe 
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calcification aortic root replacement may be per- 
formed. In our experience this is rarely necessary 
and collective data show that root replacement is 
associated with a higher operative mortality 
(Medtronic submission of collective data to the 
FDA, 1997). 
This consecutive series without patient selection 
included many elderly patients (NYHA classes IV 
or V) with left ventricular failure, unstable angina, 
endocarditis, or aortic dissection who were treated 
on an emergency basis. A hospital mortality of 6% is 
not excessive in this context and no deaths were 
attributed to the use of a stentless rather than a 
stented aortic prosthesis. 23' 24 With a well-organized 
operation (median ischemic time of 43 minutes for 
isolated valve replacement) there is no reason for 
stentless valve usage to contribute to perioperative 
mortality. 25 On the contrary, our median extubation 
time for all patients was less than 3 hours with 
hospital discharge to home between 4 and 6 days 
after the operation. 2~ The fact that 10 patients (5%) 
required a pacemaker after the operation was partly 
due to pre-existing second-degree heart block (in 2 
in whom a pacemaker was used electively) and 
partly through new complete heart block. This may 
be caused by injury to the conducting bundle during 
decalcification of the anulus. 
Detai led clinical and echocardiographic follow-up 
confirms the effectiveness of cardiac and systemic 
physiologic rehabilitation with a stentless valve. 
Very low transvalvular gradients translate into rapid 
resolution of left ventricular hypertrophy, return to 
NYHA class I, and a low incidence of valve-related 
complications.9, 2oIn 1 patient who had acute type A 
dissection 2 years after the operation, the appear- 
ance of the Freestyle valve closely resembled that of 
a normal human valve (Fig. 3), and there was no 
calcification in the xenograft aortic wall. 
Echocardiographic studies show both structural 
and functional changes in the first 2 years after valve 
replacement in patients with aortic stenosis. 9 At the 
ventricular level, hypertrophy regresses and relative 
wall thickness falls. This is associated with a striking 
increase (greater than 60%) in external work per 
unit volume of myocardium. Second, at the outflow 
tract level the physical dimensions remain constant, 
but an increase in stroke volume is associated with a 
wider flow jet and thus greater effective orifice area. 
These changes have the effect of lowering energy 
expenditure during ejection by reducing blood flow 
velocity and acceleration and, thus, transvalvular 
pressure gradients. 9 The overall result is a progres- 
sive improvement in function at both the ventricular 
and valve level that optimizes coupling between the 
heart and systemic circulation. These changes, to- 
gether with a very low incidence of aortic regurgita- 
tion, demonstrate the safety and effectiveness of our 
implantation technique. Similar changes in hemody- 
namic function have been reported for the Toronto 
SPV valve (St Jude Medical, Inc, St Paul, Minn), but 
this valve is a little less versatile and is contraindi- 
cated for patients with a size discrepancy between 
the aortic anulus and sinotubular junct ion]  9 
Surgery for aortic stenosis is one of medicine's 
great success tories, but there is increasing realiza- 
tion that the type of valve prosthesis has an impor- 
tant bearing on outcome. Given the unequivocal 
differences in rehabilitation of the left ventricle after 
use of a stentless versus stented xenograft, it be- 
comes progressively more difficult to justify the use 
of first-generation technology. 
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